Authors: Myllarniemi, M Frosen, J Ramirez, LGC Buchdunger, E Lemstrom, K Hayry, P

Citation: M. Myllarniemi et al., Selective tyrosine kinase inhibitor for the platelet-derived growth factorreceptor in vitro inhibits smooth muscle cell proliferation after reinjuryof arterial intima in vivo, CARDIO DRUG, 13(2), 1999, pp. 159-168

Authors: Koskinen, P Sihvola, R Myllarniemi, M Hayry, P Buchdunger, E Lemstrom, K

Citation: P. Koskinen et al., Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor, TRANSPLAN P, 31(1-2), 1999, pp. 102-102

Authors: Makela, S Savolainen, H Aavik, E Myllarniemi, M Strauss, L Taskinen, E Gustafsson, JA Hayry, P

Citation: S. Makela et al., Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta, P NAS US, 96(12), 1999, pp. 7077-7082

Authors: Sihvola, R Koskinen, P Myllarniemi, M Loubtchenkov, M Hayry, P Buchdunger, E Lemstrom, K

Citation: R. Sihvola et al., Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor, CIRCULATION, 99(17), 1999, pp. 2295-2301